Trials / Completed
CompletedNCT01698814
A Six-Week Safety Study of an Investigational Ophthalmic Solution
A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AL-4943A Ophthalmic Solution Administered Once Daily
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 518 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to evaluate the ocular safety of an investigational ophthalmic solution in subjects 2 years of age and older with asymptomatic eyes when administered once daily in both eyes for up to 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AL-4943A Ophthalmic Solution | |
| DRUG | AL-4943A Ophthalmic Solution Vehicle | Inactive ingredients used as placebo |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2012-10-03
- Last updated
- 2014-03-27
- Results posted
- 2014-02-28
Source: ClinicalTrials.gov record NCT01698814. Inclusion in this directory is not an endorsement.